CAS RN: 55366-56-8
hibifolin
Product Availability
Choose a grade to view its available package options.
9 package records7 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251226 |
100mg |
In stock |
| | Inquiry |
| Batchno.20250819 |
10mg |
In stock |
| | Inquiry |
| Batchno.20260419 |
1mg |
In stock |
| | Inquiry |
| Batchno.20260628 |
25mg |
In stock |
| | Inquiry |
| Batchno.20251117 |
50mg |
In stock |
| | Inquiry |
| Batchno.20260202 |
5mg |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250619 |
10mg / 25mg / 100mg |
Confirm by inquiry |
Shanghai | 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251124 |
10mg |
Out of stock |
| | Inquiry |
| Batchno.20250324 |
25mg |
Out of stock |
| | Inquiry |
-
Product code:
starshine_CAS55366-56-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
55366-56-8 / (2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-oxochromen-8-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Standard CAS: 55366-56-8
Multi CAS: Yes
Basic Information
CAS
55366-56-8
Multi CAS
Yes
Molecular Formula
C21H18O14
Molecular Weight
494.400000
Exact Mass
494.069655
InChI
InChI=1S/C21H18O14/c22-6-2-1-5(3-7(6)23)16-13(28)11(26)10-8(24)4-9(25)17(18(10)33-16)34-21-15(30)12(27)14(29)19(35-21)20(31)32/h1-4,12,14-15,19,21-25,27-30H,(H,31,32)/t12-,14-,15+,19-,21+/m0/s1
InChIKey
KHVMAMXQPVHXTJ-ORYXKJSJSA-N
Computed Properties
Structural Parameters
Heavy atom count
35
Aromatic heavy atom count
16
Fraction Csp3
0.24
Rotatable bonds
4
H-bond acceptors
13
H-bond donors
9
Molar refractivity
111.19
TPSA
247.81
LogP / Solubility
WLOGP
-0.74
MLOGP
-0.62
XLogP3
0.3
Consensus LogP
-0.35
Log S (ESOL)
-2.51
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.08
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-2.74
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.26
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
PAINS alerts
1
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5.5